ATC codes:
P01CB01
EMLc
Indication
Cutaneous leishmaniasis
ICD11 code:
1F54.1
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IM:
1.5 g per 5 mL in 5 mL ampoule
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listing for sodium stibogluconate / meglumine antimoniate on the EML and EMLc be amended to list each medicine separately with updated dosage form descriptions as follows:
Sodium stibogluconate: Injection: 100 mg/mL in 30 mL vial
Meglumine antimoniate: Injection: 1.5 g/5 mL in 5 mL ampoule